Table of Contents
The melanoma market has seen an increase in developer attention following significant breakthroughs in treatment. New approvals have raised the bar to enter the market, but with drug resistance and toxicity still major problems, there are opportunities for developers to move into this market. The entry of pipeline drugs into the market will significantly increase the value of branded sales....More »
The Largest Collection of Market Research Reports
From +200,000 authoritative sources
Talk to Robyn
(866) 682 9815
"Analytical Tool - Hematological Cancers" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in R&D and business development in hematological cancers. It is ...
Actonel (Osteoporosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Actonel (Osteoporosis) - Forecast and Market Analysis to 2022?. ...
REPORT SCOPE INTRODUCTION REASONS FOR DOING THE STUDY The spread of human immunodeficiency virus (HIV), hepatitis B and C, evolving influenza strains and antibiotic-resistant organisms have put healthcare ...
... Guidelines say People with diabetes and hypertension should be treated to a systolic blood pressure goal of 140 mmhg. Lower systolic targets (such as ...
... To target chronic pain market with a novel opioid: Slow rate of entry into cns designed to: Reduce abuse liability Reduce drowsiness Reduce respiratory depression Long-acting profile Properties ...
Company Profiles10 Companies
Reportlinker.com © Copyright 2013. All rights reserved.